Top Markets
#1 Cross Cross +12.78%
#2 Casper Network Casper Network +11.85%
#3 Gama Token Gama Token +9.13%
#4 龙虾 (Lobster) 龙虾 (Lobster) +5.14%
#5 Perle Perle +4.54%
#6 Berachain Berachain +4.52%
#7 Akedo Akedo +4.17%
#8 Humanity Humanity +3.77%
#9 The Innovation Game The Innovation Game +3.74%
#10 Palladium Network Palladium Network +3.67%
Coin of the day
Cross Cross
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Rang in Aktien #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Aktienkurs
$0.94
Zuletzt synchronisiert: 2025-02-28
Marktkapitalisierung
$2.73M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Fresh Tracks Therapeutics, Inc. (FRTX)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von Fresh Tracks Therapeutics, Inc. (FRTX)
Anzahl der ausstehenden Aktien zum December 2023: 5.91M
Laut den neuesten Finanzberichten und dem Aktienkurs von Fresh Tracks Therapeutics, Inc. beträgt die aktuelle Anzahl der ausstehenden Aktien 5.91M. Am Ende von December 2022 hatte das Unternehmen 2.81M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Fresh Tracks Therapeutics, Inc. (FRTX) von 2000 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 5.91M 0.00%
2023 5.91M 110.56%
2022 2.81M 57.33%
2021 1.78M 227.63%
2020 544.76K 710.92%
2019 67.18K -3.12%
2018 69.34K 69.47%
2017 40.91K 28.64%
2016 31.81K 9.20%
2015 29.13K 3.33%
2014 28.19K 2.24%
2013 27.57K 1.02%
2012 27.29K 19.35%
2011 22.87K 19.88%
2010 19.07K 27.61%
2009 14.95K 18.14%
2008 12.65K 1.70%
2007 12.44K 24.67%
2006 9.98K 27.89%
2005 7.80K 8.31%
2004 7.20K 12.95%
2003 6.38K 0.06%
2002 6.37K 0.24%
2001 6.36K 1.74%
2000 6.25K 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 4,194.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 951.71%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE